BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 10348008)

  • 1. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease.
    Hattersley AT; Tooke JE
    Lancet; 1999 May; 353(9166):1789-92. PubMed ID: 10348008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the glucokinase gene of the fetus result in reduced birth weight.
    Hattersley AT; Beards F; Ballantyne E; Appleton M; Harvey R; Ellard S
    Nat Genet; 1998 Jul; 19(3):268-70. PubMed ID: 9662401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin effect during embryogenesis determines fetal growth: a possible molecular link between birth weight and susceptibility to type 2 diabetes.
    Terauchi Y; Kubota N; Tamemoto H; Sakura H; Nagai R; Akanuma Y; Kimura S; Kadowaki T
    Diabetes; 2000 Jan; 49(1):82-6. PubMed ID: 10615953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal development and risk of cardiovascular diseases and diabetes type 2 in adult life.
    Szostak-Węgierek D; Szamotulska K
    Med Wieku Rozwoj; 2011; 15(3):203-15. PubMed ID: 22006475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two decades since the fetal insulin hypothesis: what have we learned from genetics?
    Hughes AE; Hattersley AT; Flanagan SE; Freathy RM
    Diabetologia; 2021 Apr; 64(4):717-726. PubMed ID: 33569631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal programming and adult health.
    Godfrey KM; Barker DJ
    Public Health Nutr; 2001 Apr; 4(2B):611-24. PubMed ID: 11683554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low birth weight, a risk factor for diseases in later life, is a surrogate of insulin resistance at birth.
    Tian M; Reichetzeder C; Li J; Hocher B
    J Hypertens; 2019 Nov; 37(11):2123-2134. PubMed ID: 31157747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal growth and insulin secretion in adult life.
    Phillips DI; Hirst S; Clark PM; Hales CN; Osmond C
    Diabetologia; 1994 Jun; 37(6):592-6. PubMed ID: 7926344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease.
    Terauchi Y; Iwamoto K; Tamemoto H; Komeda K; Ishii C; Kanazawa Y; Asanuma N; Aizawa T; Akanuma Y; Yasuda K; Kodama T; Tobe K; Yazaki Y; Kadowaki T
    J Clin Invest; 1997 Mar; 99(5):861-6. PubMed ID: 9062343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low birthweight and metabolic abnormalities in twins with increased susceptibility to Type 2 diabetes mellitus.
    Bo S; Cavallo-Perin P; Scaglione L; Ciccone G; Pagano G
    Diabet Med; 2000 May; 17(5):365-70. PubMed ID: 10872535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Low birth weight is associated with non-insulin-dependent diabetes mellitus in discordant monozygotic and dizygotic twins].
    Poulsen P; Vaag AA; Kyvik KO; Jensen DM; Beck-Nielsen H
    Ugeskr Laeger; 1998 Apr; 160(16):2382-7. PubMed ID: 9571811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity.
    Velho G; Hattersley AT; Froguel P
    Diabetologia; 2000 Aug; 43(8):1060-3. PubMed ID: 10990085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genes and intra-uterine growth retardation].
    Jeanpierre M
    Arch Pediatr; 1998; 5 Suppl 4():332S-337S. PubMed ID: 9853079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Offspring birthweight is not associated with paternal insulin resistance.
    Knight B; Shields BM; Hill A; Powell RJ; Round A; Hamilton W; Hattersley AT
    Diabetologia; 2006 Nov; 49(11):2675-8. PubMed ID: 16953379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-insulin-dependent diabetes mellitus.
    Hales CN
    Br Med Bull; 1997 Jan; 53(1):109-22. PubMed ID: 9158288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal origins of insulin resistance and the metabolic syndrome: a key role for adipose tissue?
    Meas T
    Diabetes Metab; 2010 Feb; 36(1):11-20. PubMed ID: 19815442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a Met300Val variant in Shc and studies of its relationship to birth weight and length, impaired insulin secretion, insulin resistance, and type 2 diabetes mellitus.
    Almind K; Ahlgren MG; Hansen T; Urhammer SA; Clausen JO; Pedersen O
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2241-4. PubMed ID: 10372739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth weight and the future development of diabetes. A review of the evidence.
    Phillips DI
    Diabetes Care; 1998 Aug; 21 Suppl 2():B150-5. PubMed ID: 9704243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal and neonatal programming: evidence and clinical implications.
    Nesterenko TH; Aly H
    Am J Perinatol; 2009 Mar; 26(3):191-8. PubMed ID: 19031354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal growth failure: the road to obesity, insulin resistance and cardiovascular disease in adults.
    Ong KK; Dunger DB
    Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):191-207. PubMed ID: 12064888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.